{"type":"node","id":"52","labels":["Function"],"properties":{"name":"web_crawler","id":"call_8rpbMkyVMaUoEItS2VSU8Q9x","type":"tool_call"}}
{"type":"node","id":"53","labels":["Search"],"properties":{"search_string":"H. pylori in acne vulgaris patients clinical trial enrollment count Jan-May 2018 site:nih.gov","information_to_retrieve":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 as listed on the NIH website."}}
{"type":"node","id":"54","labels":["Result"],"properties":{"source":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842965/","informations":"The Helicobacter Eradication Aspirin Trial (HEAT) is a multicentre, double-blind, randomised controlled trial investigating whether Helicobacter (H.) pylori eradication reduces hospitalisation for peptic ulcer bleeding. Recruitment started in 2012 and completed in 2017. The trial recruited participants from 1208 GP practices across the UK. Of the 188,875 invitation letters sent, 38,771 returned expressions of interest. Of these, 30,166 patients were consented to the trial, of whom 5355 H. pylori-positive participants (17.8% of those consented) were randomised. The mean age at consent was 73.1 ± 6.9 (SD) years and 72.2% of participants were male. The trial will end when 87 adjudicated events have occurred."}}
{"type":"node","id":"55","labels":["Image"],"properties":{"description":"The image depicts a stylized version of the United States flag. The flag consists of 13 horizontal stripes alternating red and white, with a blue rectangle in the upper left corner. Within the blue rectangle, there are 12 white squares arranged in a 3x4 grid pattern. This design deviates from the traditional U.S. flag, which typically has 50 stars in the blue field representing the 50 states. The overall color scheme and layout are reminiscent of the U.S. flag, but the specific arrangement of the white squares is unique to this stylized version.","caption":"U.S. flag"}}
{"type":"node","id":"56","labels":["Image"],"properties":{"description":"The image is a simple icon within a circular border. The icon depicts a classical building with columns, resembling a courthouse or a government building. The building has a triangular pediment supported by three columns. The icon and the circular border are both in blue. There is no text present in the image.","caption":"Dot gov"}}
{"type":"node","id":"57","labels":["Image"],"properties":{"description":"The image shows a green circular icon with a black outline. Inside the circle, there is a green padlock symbol. The padlock is centered within the circle and is also green, matching the color of the circle. The background of the image is transparent or white, making the green circle and padlock stand out clearly. There is no text present in the image.","caption":"Https"}}
{"type":"node","id":"58","labels":["Image"],"properties":{"description":"The image is a logo for the National Library of Medicine (NLM) and the National Center for Biotechnology Information (NCBI), which are part of the National Institutes of Health (NIH). The logo consists of two main parts: 1. On the left side, there is a stylized emblem with the letters NLM and NCBI.","caption":"NIH NLM Logo"}}
{"type":"node","id":"59","labels":["Result"],"properties":{"source":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842965/","informations":"The Helicobacter Eradication Aspirin Trial (HEAT) is a multicentre, double-blind, randomised controlled trial investigating whether Helicobacter (H.) pylori eradication reduces hospitalisation for peptic ulcer bleeding. Recruitment started in 2012 and completed in 2017. The trial recruited participants aged 60 and over who were taking aspirin (≤325 mg daily) for at least four months prior to consent. A total of 188,875 invitation letters were sent, resulting in 38,771 expressions of interest. Of these, 30,166 patients were consented to the trial, and 5355 H. pylori-positive participants were randomised. The mean age at consent was 73.1 ± 6.9 years, and 72.2% of participants were male. The trial will end when 87 adjudicated events have occurred."}}
{"type":"node","id":"60","labels":["Result"],"properties":{"source":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868213/","informations":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 is not listed in the provided content."}}
{"type":"node","id":"61","labels":["Result"],"properties":{"source":"https://clinicaltrials.gov/ct2/show/NCT01506986","informations":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 is not explicitly mentioned in the provided content."}}
{"type":"node","id":"62","labels":["Result"],"properties":{"source":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042414/","informations":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 is not explicitly mentioned in the provided content. The content primarily discusses the relationship between H. pylori and rosacea, including various studies and their findings on the correlation between H. pylori infection and rosacea, as well as the effectiveness of anti-H. pylori therapy for rosacea patients."}}
{"type":"relationship","id":"0","label":"HAS_RESULT","start":{"id":"53","labels":["Search"],"properties":{"search_string":"H. pylori in acne vulgaris patients clinical trial enrollment count Jan-May 2018 site:nih.gov","information_to_retrieve":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 as listed on the NIH website."}},"end":{"id":"59","labels":["Result"],"properties":{"source":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842965/","informations":"The Helicobacter Eradication Aspirin Trial (HEAT) is a multicentre, double-blind, randomised controlled trial investigating whether Helicobacter (H.) pylori eradication reduces hospitalisation for peptic ulcer bleeding. Recruitment started in 2012 and completed in 2017. The trial recruited participants aged 60 and over who were taking aspirin (≤325 mg daily) for at least four months prior to consent. A total of 188,875 invitation letters were sent, resulting in 38,771 expressions of interest. Of these, 30,166 patients were consented to the trial, and 5355 H. pylori-positive participants were randomised. The mean age at consent was 73.1 ± 6.9 years, and 72.2% of participants were male. The trial will end when 87 adjudicated events have occurred."}}}
{"type":"relationship","id":"160","label":"HAS_SEARCH","start":{"id":"52","labels":["Function"],"properties":{"name":"web_crawler","id":"call_8rpbMkyVMaUoEItS2VSU8Q9x","type":"tool_call"}},"end":{"id":"53","labels":["Search"],"properties":{"search_string":"H. pylori in acne vulgaris patients clinical trial enrollment count Jan-May 2018 site:nih.gov","information_to_retrieve":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 as listed on the NIH website."}}}
{"type":"relationship","id":"1","label":"HAS_RESULT","start":{"id":"53","labels":["Search"],"properties":{"search_string":"H. pylori in acne vulgaris patients clinical trial enrollment count Jan-May 2018 site:nih.gov","information_to_retrieve":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 as listed on the NIH website."}},"end":{"id":"60","labels":["Result"],"properties":{"source":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868213/","informations":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 is not listed in the provided content."}}}
{"type":"relationship","id":"161","label":"HAS_IMAGE","start":{"id":"54","labels":["Result"],"properties":{"source":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842965/","informations":"The Helicobacter Eradication Aspirin Trial (HEAT) is a multicentre, double-blind, randomised controlled trial investigating whether Helicobacter (H.) pylori eradication reduces hospitalisation for peptic ulcer bleeding. Recruitment started in 2012 and completed in 2017. The trial recruited participants from 1208 GP practices across the UK. Of the 188,875 invitation letters sent, 38,771 returned expressions of interest. Of these, 30,166 patients were consented to the trial, of whom 5355 H. pylori-positive participants (17.8% of those consented) were randomised. The mean age at consent was 73.1 ± 6.9 (SD) years and 72.2% of participants were male. The trial will end when 87 adjudicated events have occurred."}},"end":{"id":"56","labels":["Image"],"properties":{"description":"The image is a simple icon within a circular border. The icon depicts a classical building with columns, resembling a courthouse or a government building. The building has a triangular pediment supported by three columns. The icon and the circular border are both in blue. There is no text present in the image.","caption":"Dot gov"}}}
{"type":"relationship","id":"2","label":"HAS_RESULT","start":{"id":"53","labels":["Search"],"properties":{"search_string":"H. pylori in acne vulgaris patients clinical trial enrollment count Jan-May 2018 site:nih.gov","information_to_retrieve":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 as listed on the NIH website."}},"end":{"id":"61","labels":["Result"],"properties":{"source":"https://clinicaltrials.gov/ct2/show/NCT01506986","informations":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 is not explicitly mentioned in the provided content."}}}
{"type":"relationship","id":"162","label":"HAS_IMAGE","start":{"id":"54","labels":["Result"],"properties":{"source":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842965/","informations":"The Helicobacter Eradication Aspirin Trial (HEAT) is a multicentre, double-blind, randomised controlled trial investigating whether Helicobacter (H.) pylori eradication reduces hospitalisation for peptic ulcer bleeding. Recruitment started in 2012 and completed in 2017. The trial recruited participants from 1208 GP practices across the UK. Of the 188,875 invitation letters sent, 38,771 returned expressions of interest. Of these, 30,166 patients were consented to the trial, of whom 5355 H. pylori-positive participants (17.8% of those consented) were randomised. The mean age at consent was 73.1 ± 6.9 (SD) years and 72.2% of participants were male. The trial will end when 87 adjudicated events have occurred."}},"end":{"id":"58","labels":["Image"],"properties":{"description":"The image is a logo for the National Library of Medicine (NLM) and the National Center for Biotechnology Information (NCBI), which are part of the National Institutes of Health (NIH). The logo consists of two main parts: 1. On the left side, there is a stylized emblem with the letters NLM and NCBI.","caption":"NIH NLM Logo"}}}
{"type":"relationship","id":"3","label":"HAS_RESULT","start":{"id":"53","labels":["Search"],"properties":{"search_string":"H. pylori in acne vulgaris patients clinical trial enrollment count Jan-May 2018 site:nih.gov","information_to_retrieve":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 as listed on the NIH website."}},"end":{"id":"62","labels":["Result"],"properties":{"source":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042414/","informations":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 is not explicitly mentioned in the provided content. The content primarily discusses the relationship between H. pylori and rosacea, including various studies and their findings on the correlation between H. pylori infection and rosacea, as well as the effectiveness of anti-H. pylori therapy for rosacea patients."}}}
{"type":"relationship","id":"163","label":"HAS_SEARCH","start":{"id":"52","labels":["Function"],"properties":{"name":"web_crawler","id":"call_8rpbMkyVMaUoEItS2VSU8Q9x","type":"tool_call"}},"end":{"id":"53","labels":["Search"],"properties":{"search_string":"H. pylori in acne vulgaris patients clinical trial enrollment count Jan-May 2018 site:nih.gov","information_to_retrieve":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 as listed on the NIH website."}}}
{"type":"relationship","id":"102","label":"HAS_RESULT","start":{"id":"53","labels":["Search"],"properties":{"search_string":"H. pylori in acne vulgaris patients clinical trial enrollment count Jan-May 2018 site:nih.gov","information_to_retrieve":"The actual enrollment count of the clinical trial on H. pylori in acne vulgaris patients from Jan-May 2018 as listed on the NIH website."}},"end":{"id":"54","labels":["Result"],"properties":{"source":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842965/","informations":"The Helicobacter Eradication Aspirin Trial (HEAT) is a multicentre, double-blind, randomised controlled trial investigating whether Helicobacter (H.) pylori eradication reduces hospitalisation for peptic ulcer bleeding. Recruitment started in 2012 and completed in 2017. The trial recruited participants from 1208 GP practices across the UK. Of the 188,875 invitation letters sent, 38,771 returned expressions of interest. Of these, 30,166 patients were consented to the trial, of whom 5355 H. pylori-positive participants (17.8% of those consented) were randomised. The mean age at consent was 73.1 ± 6.9 (SD) years and 72.2% of participants were male. The trial will end when 87 adjudicated events have occurred."}}}
{"type":"relationship","id":"103","label":"HAS_IMAGE","start":{"id":"54","labels":["Result"],"properties":{"source":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842965/","informations":"The Helicobacter Eradication Aspirin Trial (HEAT) is a multicentre, double-blind, randomised controlled trial investigating whether Helicobacter (H.) pylori eradication reduces hospitalisation for peptic ulcer bleeding. Recruitment started in 2012 and completed in 2017. The trial recruited participants from 1208 GP practices across the UK. Of the 188,875 invitation letters sent, 38,771 returned expressions of interest. Of these, 30,166 patients were consented to the trial, of whom 5355 H. pylori-positive participants (17.8% of those consented) were randomised. The mean age at consent was 73.1 ± 6.9 (SD) years and 72.2% of participants were male. The trial will end when 87 adjudicated events have occurred."}},"end":{"id":"55","labels":["Image"],"properties":{"description":"The image depicts a stylized version of the United States flag. The flag consists of 13 horizontal stripes alternating red and white, with a blue rectangle in the upper left corner. Within the blue rectangle, there are 12 white squares arranged in a 3x4 grid pattern. This design deviates from the traditional U.S. flag, which typically has 50 stars in the blue field representing the 50 states. The overall color scheme and layout are reminiscent of the U.S. flag, but the specific arrangement of the white squares is unique to this stylized version.","caption":"U.S. flag"}}}
{"type":"relationship","id":"104","label":"HAS_IMAGE","start":{"id":"54","labels":["Result"],"properties":{"source":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842965/","informations":"The Helicobacter Eradication Aspirin Trial (HEAT) is a multicentre, double-blind, randomised controlled trial investigating whether Helicobacter (H.) pylori eradication reduces hospitalisation for peptic ulcer bleeding. Recruitment started in 2012 and completed in 2017. The trial recruited participants from 1208 GP practices across the UK. Of the 188,875 invitation letters sent, 38,771 returned expressions of interest. Of these, 30,166 patients were consented to the trial, of whom 5355 H. pylori-positive participants (17.8% of those consented) were randomised. The mean age at consent was 73.1 ± 6.9 (SD) years and 72.2% of participants were male. The trial will end when 87 adjudicated events have occurred."}},"end":{"id":"57","labels":["Image"],"properties":{"description":"The image shows a green circular icon with a black outline. Inside the circle, there is a green padlock symbol. The padlock is centered within the circle and is also green, matching the color of the circle. The background of the image is transparent or white, making the green circle and padlock stand out clearly. There is no text present in the image.","caption":"Https"}}}